Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb:31 Suppl 24:22-24.
doi: 10.1111/pai.13170.

Pediatric angioedema: Essential features and preliminary results from the Hereditary Angioedema Global Registry in Italy

Mauro Cancian  1 , Francesca Perego  2 , Riccardo Senter  1 , Francesco Arcoleo  3 , Tiziana De Pasquale  4 , Alessandra Zoli  5 , Marco Cicardi  2   6 , Andrea Zanichelli  7
Affiliations

Pediatric angioedema: Essential features and preliminary results from the Hereditary Angioedema Global Registry in Italy

Mauro Cancian et al. Pediatr Allergy Immunol. 2020 Feb.

Abstract

Isolated angioedema, which is a localized, non-pitting, and transient swelling of the subcutaneous or submucosal tissue not associated with pruritus, urticaria, or anaphylaxis, may be classified, based on genetic pattern and mediators, respectively, as acquired or hereditary and histamine- or non-histamine-induced. The pediatric population with C1-INH-HAE (Hereditary angioedema due to C1-inhibitor deficiency) is mostly symptomatic. The frequency of symptoms in such a population compared to adults seems to be lower, but we need more prospective data to conclude on this point. The HGR (Hereditary angioedema global registry), which collects symptoms in real time, will probably provide such information. In terms of treatments, pediatric patients are significantly disadvantaged due to the few studies aimed at registering treatment for this population.

Keywords: C1-inhibitor; HGR; ITACA; disease registry; hereditary angioedema; pediatric.

PubMed Disclaimer

References

REFERENCES

    1. Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69:602-616.
    1. Reshef A, Kidon M, Leibovich I. The story of angioedema: from Quincke to Bradykinin. Clinic Rev Allerg Immunol. 2016;51:121-139.
    1. Caccia S, Suffritti C, Cicardi M. Pathophysiology of hereditary angioedema. Pediatr Allergy Immunol Pulmonol. 2014;27:159-163.
    1. Cicardi M, Zuraw BL. Angioedema due to bradykinin dysregulation. J Allergy Clin Immunol Pract. 2018;6:1132-1141.
    1. Rubinstein E, Stolz LE, Sheffer AL, et al. Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. BMC Gastroenterol. 2014;14:71-79.

Substances

LinkOut - more resources